Skip to main content

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  241.29
-0.44 (-0.18%)
AAPL  255.47
-2.81 (-1.09%)
AMD  242.21
-9.97 (-3.95%)
BAC  53.15
+0.07 (0.13%)
GOOG  334.92
-3.74 (-1.10%)
META  721.35
-16.96 (-2.30%)
MSFT  433.85
+0.35 (0.08%)
NVDA  191.77
-0.74 (-0.38%)
ORCL  165.73
-3.28 (-1.94%)
TSLA  427.45
+10.89 (2.61%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.